Ascendis Pharma A/S Derivative Financial Liabilities
Ascendis Pharma A/S (ASND) had Derivative Financial Liabilities of EUR 256.23 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:DerivativeFinancialLiabilities · last filed 2026-02-11
- 2025-12-31: Derivative Financial Liabilities 256.23M EUR.
- 2025-09-30: Derivative Financial Liabilities 233.76M EUR.
- 2025-06-30: Derivative Financial Liabilities 186.58M EUR.
- 2025-03-31: Derivative Financial Liabilities 174.58M EUR.
| Period end | Derivative Financial Liabilities |
|---|---|
| 2025-12-31 | 256.23M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 233.76M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 186.58M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 174.58M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 150.67M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 168.35M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 159.06M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 197.29M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 143.30M EUR 20-F · filed 2025-02-12 |
| 2023-03-31 | 116.77M EUR 6-K · filed 2023-04-27 |
| 2022-12-31 | 157.95M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 132.73M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 102.03M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 141.38M EUR 6-K · filed 2022-05-11 |
| 2022-03-25 | 142.50M EUR 20-F · filed 2023-02-16 |
| 2021-12-31 | 0.00 EUR 6-K · filed 2022-11-02 |